Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

POWERFLEET, INC. (AIOT)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 3
  • 1 comments

Powerfleet Sets Fourth Quarter Fiscal 2026 Conference Call for Monday, June 15, 2026, at 8:30 a.m. ET

Market reaction Comment Full text

HONEYWELL INTERNATIONAL INC (HON)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 8
  • 1 comments

HONEYWELL APPOINTS JILL EVANKO TO BOARD OF DIRECTORS

Market reaction Comment Full text

CURBLINE PROPERTIES CORP. (CURB)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

Curbline Properties Second Quarter 2026 Investment and Capital Markets Update

Market reaction Comment Full text

KARYOPHARM THERAPEUTICS INC. (KPTI)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 5
  • 1 comments

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

Market reaction Comment Full text

DHI GROUP, INC. (DHX)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 8
  • 1 comments

DHI Group to Present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on June 4, 2026

Market reaction Comment Full text

ROLLINS INC (ROL)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 7
  • 1 comments

ROLLINS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

Market reaction Comment Full text

WF INTERNATIONAL LTD. (WXM)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 6
  • 1 comments

WF International Limited Announces Share Consolidation

Market reaction Comment Full text

FULCRUM THERAPEUTICS, INC. (FULC)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 7
  • 1 comments

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Market reaction Comment Full text

AKEBIA THERAPEUTICS, INC. (AKBA)

  • Business News
  • June 01, 2026, 20:05 UTC
  • 2
  • 1 comments

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text
  • Previous
  • 1884
  • 1885
  • 1886
  • 1887
  • 1888
  • Next

Search

News categories

  • Technical Exchange News(13768)
  • Event(6229)
  • SEC News(356548)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(195949)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin